When used alone, the risk of hypoglycaemia is low
10.1056/NEJMoa1607141
2022 JAMA Internal Medicine meta-analysis: pooling 76 randomised controlled trials, GLP-1 receptor agonist use was associated with a relative risk of 1.37 for biliary disease compared with placebo or other treatments
It is the fuel to generate ROS
In fact, glutathione is actually found in every cell in the body thats how prevalent the antioxidant is and how vital it is for so many important functions, including making DNA, breaking down free radicals, and supporting regular immune function
Sulfur burps are one of the most talked-about side effects of GLP-1 medications like semaglutide and tirzepatide, even though GI effects like bloating, nausea, and constipation are more common